In this live webinar, the speakers will outline both the importance of a coherent endpoint strategy as well as the importance of leveraging scientific leadership early-on in trial design.
Leading thoracic physician researcher and Chair of the Lung Foundation of Australia, Professor Christine Jenkins will use examples from her long-term partnership as a scientific leader at George Clinical to discuss:
Professor Jenkins will also discuss:
Dr. Jenkins’ research is focused on the clinical management of airways disease and patient reported outcomes in response to therapeutic interventions. She is Head of the Respiratory Group at The George Institute for Global Health; Senior Staff Specialist in Thoracic Medicine at Concord Hospital, Sydney; Clinical Professor and Head of Respiratory Discipline at University of Sydney; and Professor of Respiratory Medicine at UNSW Sydney. She also chairs the National Asthma Campaign and the Federal Government’s National Asthma Advisory Group.
Dr. Jenkins has been Principal Investigator and has led many investigator-initiated and competitively funded clinical trials in airways disease. She is an active clinician and has had major roles in advocacy and leadership for lung health in Australia, chairing many local and international guidelines and implementation initiatives to enhance resources, skills, capacity and clinical outcomes in airways disease. She is on the Board of the Lung Foundation Australia, and is a member of the Thoracic Society of Australia and New Zealand, the American Thoracic Society, European Respirator Society and the Asia-Pacific Society of Respirology.
Meet with George Clinical! Contact us to schedule a time now.